key: cord-0848215-40mxkojm authors: Kok, Hing Cheong; Nair, Dinesh; Wong, Ke Juin; Fong, Siew Moy title: Multisystem inflammatory syndrome in children and Kawasaki disease in infants: 2 sides of the same coin? date: 2021-10-07 journal: Clin Exp Pediatr DOI: 10.3345/cep.2021.00913 sha: 85adcccfa78e0000bbe4a035ce0b8e71e12af5b5 doc_id: 848215 cord_uid: 40mxkojm nan To the editor, The world has been plagued by the novel severe acute respira tory syndrome coronavirus 2 (SARSCoV2) causing the global pandemic of coronavirus disease 2019 (COVID19). A new dis ease entity, called multisystem inflammatory syndrome in children (MISC), emerged in late April to early May 2020, affected clu sters of children in Europe and North America, and showed a temporal association with SARSCoV2 infection. This article presents an infant with MISC and features of Kawasaki disease shock syndrome (KDSS) who was treated in a tertiary hospital in Sabah, Malaysia. This study aimed to assess the labo ratory and clinical characteristics of MISC in infants, along with its simil arities and differences with Kawasaki disease (KD). A healthy 4monthold girl was diagnosed with SARSCoV2 infection. One month after being diagnosed, she presented with fever, vomiting, rash, bilateral nonpurulent conjunctivitis, dry fissured red lips, and poor feeding. She went into shock 12 hours after admission and was transferred to the pediatric intensive care unit for invasive mechanical ventilation. Her white blood cell count was 5.8×10 3 /μL (absolute lympho cyte count, 1.5×10 3 /μL), her platelet count was 65×10 3 /μL, and she had hypoalbuminemia (24 g/L). Her inflammatory markers were elevated: Creactive protein, 102.6 mg/L; and ferritin, 504 ng/mL. She had a deranged coagulation profile (prothrombin time, 17 seconds; activated partial thromboplastin time, 75.1 seconds; international normalized ratio, 1.45) and an elevated Ddimer level (2.3 μg/mL). Her chest radiography findings were normal. She had an unremitting fever of up to 39.7°C daily. She was hypotensive and required intravenous (IV) adrenaline and nora drenaline. Given this constellation of findings, she received IV immunoglobulin (IVIG) 1 g/kg/dose for 2 days, IV methylpredni solone 2 mg/kg daily for 5 days, and oral prednisolone. She was also empirically treated with IV piperacillintazobactam, which was discontinued after the blood culture result was negative. No virus was detected in the respiratory multiplex panel. Her serum SARSCoV2 antibody test results were positive for Ig G. On day 4 of hospitalization, her fever subsided after completion of IVIG therapy. Echocardiography revealed normal coronary arteries and a minimal pericardial effusion. She was weaned off of the vasopressors and extubated on day 7 of hospitalization. Oral aspirin and subcutaneous enoxaparin were administered to treat thrombocytosis. The patient was discharged 19 days after hospitalization. Followup echocardiography 1 month later re vealed normal coronary arteries and resolved pericardial effusion. We compared 5 infants from published case reports in PubMed, who fulfilled case definitions for MISC of the Centers for Dis ease Control 1) or World Health Organization 2) with our case de scribed above. 37) These cases were further analyzed to determine if they fulfilled the diagnostic criteria for KD, incomplete KD, or KDSS ( Table 1) . None of the infants had any underlying comorbidity except for infant 2, who was born prematurely (gestational age, 26 weeks); had chronic lung disease, swallowing difficulty, and peri ventricular hemorrhage; and had recently undergone a surgical gastrostomy procedure. 3) All infants presented with persistent fever for at least 3day duration. Among the infants that fulfilled the diagnostic criteria of KD or incomplete KD, the most consis tent features were rash and conjunctival injection. All but infant 2 received IVIG; this was the only infant who died. MISC is a new disease entity with a heterogeneous clinical presentation. It seems to predominantly affect older children, whereby the median age reported was 7-9 years. 8, 9) The majority of the above infants (5 of 6, 83%) presented with features con sistent with KD, incomplete KD, or KDSS with prominent mucocutaneous features (rashes, cracked lips, and conjunctival injection) and cardiovascular involvement. These 5 infants were aged between 2 and 6 months in contrast to the mean age at pre sentation of typical KD of 3.4 years. 10) It is important to note that typical KD is rarely reported in infants younger than 6 months of age. Furthermore, most MISC series reported maletofemale ratios of approximately 1.5:1, but there was a female preponde rance of 2:1 in this cohort. Multisystemic involvement, especially of the gastrointestinal and cardiovascular systems with shock, was more prominent in MISC than in typical KD. Inflammatory markers were markedly elevated in contrast to typical KD. 8) Moreover, MISC shows many similarities to KDSS, a rare form of KD. An important prerequisite for the diagnosis of MISC is expo sure to SARSCoV2, confirmed by a positive reverse transcrip tionpolymerase chain reaction (RTPCR), antigen, or serology test. Past or previous infections were identified in most MISC The younger age, female preponderance, and KDlike presen tation in this cohort may suggest that these infants were geneti cally predisposed. SARSCoV2 may trigger activation of the in flammatory cascade in these infants. Another possible mechanism is the presence of autoantibodies due to Tcell recognition of self antigens or viral antigens expressed on infected cells, resulting cases evidenced by positive antibody tests, and only a third had positive RTPCR findings for SARSCoV2. 9) A notable difference in the infants in this study was that a large proportion of infants (4 of 6, 66%) had acute current SARSCoV2 infection as evidenced by positive RTPCR tests rather than previous infections evi denced by positive antibody tests (2 of 6, 33%) ( Table 1) . in a hyperimmune response state and cytokine storm caused by dysregulated immune responses. 9) KD usually responds well to IVIG therapy, and only 10%-20% of cases are resistant to IVIG requiring either corticosteroid or biologics. On the other hand, the marked hyperinflammatory response in children with MISC often warrants combination therapy with both IVIG and corticosteroids. This study had several limitations. First, we reviewed only a small number of infants and were not able to draw any definite conclusions regarding ethnicity or sex predilection. Moreover, comparing laboratory findings was difficult because some labo ratory results were not available. In conclusion, MISC shows similarities to KD, especially KDSS, which most likely is a consequence of dysregulated immune responses secondary to SARSCoV2 infection. Hence, the early recognition and diagnosis of MISC, followed by prompt treat ment with IVIG and corticosteroids, will lead to favorable out comes. The current diagnostic criteria for MISC do not adequa tely differentiate MISC from severe COVID19; further refinement would better facilitate its diagnosis. ORCID: Hing Cheong Kok iD https://orcid.org/0000000297815905 Centers for Disease Control and Prevention. Multisystem Inflammatory Syndrome in Children (MISC) Associated with Coronavirus Disease 2019 (COVID19) Centers for Disease Control and Prevention Multisystem inflammatory syndrome in child ren and adolescents temporally related to COVID19 World Health Organisation Multisystem inflammatory syndrome in a child associated with coronavirus disease in the Brazilian Amazon: fatal outcome in an infant Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus2 in an 8weekold infant Novel coronavirus mimicking Kawasaki disease in an infant Incomplete Kawasaki disease as presentation of COVID19 infection in an infant: a case report COVID19 and Kawasaki disease: novel virus and novel case Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARSCoV2 COVID19 and multisystem inflammatory syndrome in children and adolescents Schon berger LB. Hospitalizations for Kawasaki syndrome among children in the United States